China Medical System Holdings Limited

HKEX:0867.HK

12.98 (HKD) • At close July 22, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 7,468.998,013.2859,150.3478,337.2216,945.9646,073.6245,433.4495,348.8384,900.8123,553.4312,945.1312,201.4191,759.3541,322.32876.68658.587495.421378.016293.521
Cost of Revenue 2,046.7961,904.1192,114.52,090.2831,811.7491,527.3081,516.5751,870.5371,988.9111,507.3351,290.5031,000.982724.449573.645358.659243.049189.945132.5891.27
Gross Profit 5,422.1946,109.1667,035.8476,246.9385,134.2154,546.3163,916.8743,478.3012,911.9012,046.0961,654.6281,200.4371,034.905748.675518.021415.538305.475245.436202.252
Gross Profit Ratio 0.7260.7620.7690.7490.7390.7490.7210.650.5940.5760.5620.5450.5880.5660.5910.6310.6170.6490.689
Reseach & Development Expenses 329.982195.134125.431114.76166.51750.42100000000013.91515.52511.92917.622
General & Administrative Expenses 780.093656.628636.612440.995251.18251.29243.265221.974221.714192.721151.896142.434117.40896.40682.41750.5247.35863.75939.65
Selling & Marketing Expenses 2,661.6482,511.3412,721.3122,540.1472,053.2331,939.1671,672.5951,382.151,173.76814.122631.145457.645359.116270.004205.386169.607127.138101.789102.568
SG&A 3,441.7413,167.9693,357.9242,981.1422,304.4132,190.4571,915.861,604.1241,395.4741,006.843783.041600.079476.525366.409287.803220.128174.496165.548142.219
Other Expenses -82.0430-7.4731.606-1.790.9911.476-3.8733.6771.539-3.215.4543.739000000
Operating Expenses 3,689.683,363.1033,390.2923,030.8092,324.0032,143.081,904.5611,577.6251,370.144977.76747.669577.323463.979366.409285.329234.043190.021176.9159.186
Operating Income 1,732.5142,712.8484,020.4763,865.8123,281.7052,636.5122,277.9762,250.4011,693.5551,240.5551,089.731785.524693.364433.759233.806181.474123.20775.67342.785
Operating Income Ratio 0.2320.3390.4390.4640.4720.4340.4190.4210.3460.3490.370.3570.3940.3280.2670.2760.2490.20.146
Total Other Income Expenses Net 277.793160.923117.295240.465.877-148.814-5.939-92.243-41.316-4.24539.77348.71318.819-5.87-0.504-2.16417.8527.042-0.803
Income Before Tax 2,010.3072,873.7713,762.853,456.5892,816.0892,487.6982,006.3741,808.4331,500.4411,064.0911,129.504671.178589.745427.889229.714183.85133.30675.57841.982
Income Before Tax Ratio 0.2690.3590.4110.4150.4050.410.3690.3380.3060.2990.3840.3050.3350.3240.2620.2790.2690.20.143
Income Tax Expense 397.227489.341486.655431.325260.389532.004161.776138.494122.52467.62586.50948.9358.39235.9526.15241.62330.61912.21411.189
Net Income 1,619.7882,400.943,258.9923,017.4022,530.3981,960.7121,849.8831,674.8071,375.936995.9351,045.702623.144530.797391.405202.872141.23101.99163.44531.299
Net Income Ratio 0.2170.30.3560.3620.3640.3230.340.3130.2810.280.3550.2830.3020.2960.2310.2140.2060.1680.107
EPS 0.670.981.331.221.020.790.740.670.550.40.430.260.220.160.10.081.150.780.42
EPS Diluted 0.670.981.331.221.020.790.740.670.550.40.430.260.220.160.10.0791.150.770.42
EBITDA 2,308.1552,922.1493,849.673,704.6793,051.9252,748.0082,200.0082,087.1011,692.2861,165.951914.035649.852590.082459.899244.173200.258133.88682.86246.59
EBITDA Ratio 0.3090.3650.4210.4440.4390.4520.4050.390.3450.3280.310.2950.3350.3480.2790.3040.270.2190.159